Clinical Trial Update: SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update for relugolix in women with endometriosis-associated pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Myovant Sciences GmbH | Conditions: Endometriosis Related Pain | Phase 3 | Status: COMPLETED